Synairgen (LON:SNG) Shares Cross Below 200-Day Moving Average – Time to Sell?
by Mitch Edgeman · The Markets DailySynairgen plc (LON:SNG – Get Free Report) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 4.94 ($0.06) and traded as low as GBX 4.60 ($0.06). Synairgen shares last traded at GBX 4.77 ($0.06), with a volume of 129,781 shares traded.
Synairgen Stock Performance
The company has a debt-to-equity ratio of 0.09, a current ratio of 6.77 and a quick ratio of 6.35. The stock’s 50-day moving average price is GBX 4.03 and its 200-day moving average price is GBX 4.93. The company has a market cap of £9.60 million, a P/E ratio of -158.83 and a beta of -2.23.
About Synairgen
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.
See Also
- Five stocks we like better than Synairgen
- Which Wall Street Analysts are the Most Accurate?
- From PACs to Portfolios: Billionaire Bets and Investor Reactions
- ETF Screener: Uses and Step-by-Step Guide
- AppLovin Stock Quadruples: What’s Behind the Bullish Sentiment?
- Differences Between Momentum Investing and Long Term Investing
- Battle of the Retailers: Who Comes Out on Top?